STAT1 min citite
STAT+: Pharmalittle: Pfizer And BioNTech Start Trial Of Omicron-targeted Vaccine; Insulin Makers Boost Lobbying Spending
Pfizer and BioNTech have started a trial evaluating an adapted version of their Covid-19 vaccine targeting the Omicron variant of the coronavirus.
STAT1 min citite
STAT+: Pharmalittle: Did Hal Barron Hit His Goals Before Leaving Glaxo? FDA Rejects Drugs From Merck And Pfizer
So here is the big question for Hal Barron as he departs GlaxoSmithKline: Did he accomplish his mission to turnaround its labs?
STAT1 min citite
STAT+: Pharmalittle: Alzheimer’s Patient Groups To Protest Medicare Plan For Biogen Drug; Cancer Combo Treatments Are Questioned
Alzheimer's patient groups are planning publicity and lobbying campaigns to protest a Medicare coverage proposal they say could delay the use of new drugs for 10 years.
STAT1 min citite
STAT+: Pharmalittle: 27 Companies Will Make Generic Merck Covid Pills; Drug-resistant Infections Are Deadlier Than HIV Or Malaria
The Medicines Patent Pool has signed agreements with 27 generic manufacturers to make and supply the Covid-19 pill from Merck to 105 low- and middle-income countries.
STAT1 min citite
STAT+: Pharmalittle: Disease ‘Reversal’ Startup Launches With $3 Billion And Biotech Vets; Network Distributed Fake Gilead HIV Meds
A team of biotech veterans have raised $3 billion to create Altos Labs, which will aim to battle disease by reprogramming the fundamental machinery of living cells.
STAT1 min citite
STAT+: Pharmalittle: Unilever Will Pursue Glaxo Consumer Unit Despite Rejection; Endo Settles Florida Opioid Case For $65 Million
Unilever has signaled it will continue pursuing a blockbuster deal to buy the GlaxoSmithKline consumer health care unit after an earlier offer was rejected.
STAT1 min citite
STAT+: Pharmalittle: Senate Committee Advances Califf FDA Nomination; Bedraggled Biogen Writes A Shopping List
Desperate to reverse the turmoil surrounding its controversial Alzheimer’s treatment, Biogen has a shopping list of potential acquisitions.
STAT1 min citite
STAT+: Pharmalittle: Lilly And Roche Are Also Losers In The Medicare Alzheimer’s Decision; Former CRO Owner Pleads Guilty To Falsifying Data
Medicare may have released a plan to restrict access to the controversial Biogen Alzheimer’s drug, but the biggest losers may be other drug makers readying treatments.
STAT1 min citite
STAT+: Pharmalittle: Medicare Proposes To Restrict Coverage Of Biogen Alzheimer’s Drug; Pfizer To Cut Its U.S. Sales Staff
Medicare plans to cover the controversial Biogen Alzheimer’s drug, but only for certain patients enrolled in clinical trials.
STAT1 min citite
STAT+: Pharmalittle: Pfizer Makes A Major Push Into MRNA Technology; Medicare Decision On Alzheimer’s Drug May Hurt State Budgets
A preliminary decision on Medicare coverage for the Biogen Alzheimer's drug is due this week, and it has major implications for state Medicaid programs.
STAT1 min citite
STAT+: Pharmalittle: Investors Want CEO Pay Tied To Global Vaccine Equity; FDA Ordered To Release More Documents On Pfizer Covid Shot
More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to tie executive compensation to vaccine equity.
STAT1 min citite
STAT+: Pharmalittle: More Top Hospitals Aren’t Offering Biogen Alzheimer’s Drug; Pfizer May Lower Covid Pill Price In Poor Countries Until Supplies Rise
The organization that negotiates supply contracts on behalf of more than 95% of the nation’s academic hospitals estimates just one to five vials of the Biogen Alzheimer's medicine are ordered…
STAT1 min cititeAmerican Government
STAT+: Pharmalittle: U.S. Doubles Order Of Pfizer Covid-19 Pill; Court Revives Suit Claiming Drug Makers Funded Terrorism In Iraq
Three drug makers each donated tens of thousands of dollars last year to Republican members of Congress who voted against certifying President Biden’s election, despite pledges to withhold or pause…
STAT1 min citite
STAT+: Pharmalittle: Pharma Raises Median Drug Prices By 4.9%, So Far; Covid Forces Some Lawmakers To Ponder Pharma Gifts
As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a median of 4.9% on more than 450 prescription medicines.
STAT1 min citite
STAT+: Pharmalittle: New Covid-19 Vaccine Developers Expect Nothing In Return; COVAX Distribution Falls Short Of Goals
For some vaccine makers, the pandemic has generated billions of dollars in profits, but developers of a new vaccine rolling out soon in India are getting zilch.
STAT1 min cititeDiscrimination & Race Relations
What Racism In Medicine Takes From Us
While physicians of color are more likely to serve marginalized communities, medical training is an intense reenactment of the injustices that seeded marginalization in the first place.
STAT1 min citite
STAT+: Pharmalittle: Japan Panel Nixes Biogen Alzheimer’s Drug; Oxfam Urges SEC To Probe Moderna Over Patent Dispute Remarks
Oxfam America has filed a complaint with securities regulators accusing Moderna of providing “misleading statements” and concealing material information about its dispute with the U.S. government over Covid-19 vaccine patents.
STAT1 min citite
STAT+: Pharmalittle: Moderna Says Booster Shot Raises Antibody Levels To Thwart Omicron; Sanofi Buys Yet Another Biotech
Moderna (MRNA) disclosed that a booster shot of its coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant.
STAT1 min citite
STAT+: Pharmalittle: Biogen Cuts Price Of Alzheimer’s Drug In Half And Plans Cost Cuts; Moderna Test Suggests Booster Works Against Omicron
Moderna reported that a third dose of its Covid-19 vaccine increased immune responses against the Omicron coronavirus variant compared with two doses in lab tests.
STAT1 min cititeDiscrimination & Race Relations
STAT+: Pharmalittle: Judge Reverses Purdue Pharma Bankruptcy Plan; FDA Eases Access Restrictions On Abortion Pills
The FDA permanently removed a controversial restriction on access to abortion pills by allowing patients to receive the medicine by mail.
STAT1 min citite
STAT+: Pharmalittle: Biogen To Start Large Trial To Confirm Alzheimer’s Drug Benefits; FDA To Decide On Easier Access To Abortion Pill
Biogen expects to begin a large clinical trial next May to confirm the benefits of its Alzheimer’s treatment, pending clearance from the FDA.
STAT1 min citite
STAT+: Pharmalittle: Califf Sails Through Hearing For Top FDA Job; J.P. Morgan Goes Virtual After Big Biotechs Pull Out
Robert Califf escaped largely unscathed from a two-hour hearing vetting him to be U.S. Food and Drug Administration commissioner.
STAT1 min citite
STAT+: Pharmalittle: Pfizer Covid Pill Retains 89% Efficacy In Full Study; Senate Committee Holds Hearing On FDA Commissioner
The Pfizer pill to treat Covid-19 retained its 89% efficacy at preventing hospitalization and death in the full results of a study of high-risk patients.
STAT1 min citite
STAT+: Pharmalittle: Pfizer To Pay $6.7 Billion For Arena And A Bowel Disease Drug; ASH Brings Flood Of Data Readouts
Pfizer has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline.
STAT1 min citite
STAT+: Pharmalittle: Fauci Unconvinced Omicron-specific Vaccines Are Needed; J&J Rebuffed Warnings About A Diabetes Drug
Anthony Fauci is not convinced Covid-19 vaccine manufacturers are going to need to produce an Omicron-specific version of their vaccines.
STAT1 min cititeSmall Business & Entrepreneurs
STAT+: Pharmalittle: Biotech VC Firms Charge Their Startups ‘Consulting’ Fees; FDA Authorizes Preventive Covid Antibody Cocktail
Some of the biggest names in biotech venture capital have charged their startups millions of dollars in “consulting fees,” effectively taking back a small portion of the money they invested.
STAT1 min citite
STAT+: Pharmalittle: Biogen Prepares For Large Layoffs; Pfizer Covid Booster Neutralized Omicron But Variant May Elude Two Doses
Biogen is preparing for its largest-ever layoff in which more than 1,000 employees are expected to lose their jobs after the disastrous launch of Aduhelm.
STAT1 min citite
STAT+: Pharmalittle: Glaxo And Vir Antibody Remains Effective Against Omicron; Biden Talks Up Drug-pricing Reform
GlaxoSmithKline and Vir Biotechnology reported their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies.
STAT1 min citite
STAT+: Pharmalittle: Covid-19 Pills May Take Longer To Reach Poor Countries; J&J Covid Booster May Be As Beneficial As A Third Pfizer Shot
People who received the Pfizer-BioNTech Covid vaccines may get as much benefit from a J&J booster shot as a Pfizer one.
STAT1 min citite
STAT+: Pharmalittle: FDA Plans Rapid Review Of Omicron Vaccines And Drugs; Califf Would Keep Woodcock At FDA
The FDA is laying the groundwork for the rapid review of Omicron-targeted vaccines and drugs if they turn out to be needed.
... Sau descoperiți ceva nou